Antunes F - Search Results

1

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.

Borges ÁH, Lundgren JD, Ridolfo A, Katlama C, Antunes F, Grzeszczuk A, Blaxhult A, Mitsura VM, Doroana M, Battegay M, Gargalianos P, Mocroft A; EuroSIDA in EuroCOORD. Borges ÁH, et al. Among authors: antunes f. AIDS. 2014 Nov 13;28(17):2565-71. doi: 10.1097/QAD.0000000000000433. AIDS. 2014. PMID: 25574959

2

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM. van Leeuwen R, et al. Among authors: antunes f. AIDS. 2003 May 2;17(7):987-99. doi: 10.1097/00002030-200305020-00007. AIDS. 2003. PMID: 12700448 Clinical Trial.

3

Changing incidence of central nervous system diseases in the EuroSIDA cohort.

d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J; EuroSIDA Study Group. d'Arminio Monforte A, et al. Among authors: antunes f. Ann Neurol. 2004 Mar;55(3):320-8. doi: 10.1002/ana.10827. Ann Neurol. 2004. PMID: 14991809

4

The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.

Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, Antunes F, Stellbrink HJ, Phillips AN, Lundgren JD. Mocroft A, et al. Among authors: antunes f. Cancer. 2004 Jun 15;100(12):2644-54. doi: 10.1002/cncr.20309. Cancer. 2004. PMID: 15197808 Free article.

5

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group. Konopnicki D, et al. Among authors: antunes f. AIDS. 2005 Mar 24;19(6):593-601. doi: 10.1097/01.aids.0000163936.99401.fe. AIDS. 2005. PMID: 15802978

6

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.

Mocroft A, Phillips AN, Ledergerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgren JD. Mocroft A, et al. Among authors: antunes f. AIDS. 2006 May 12;20(8):1141-50. doi: 10.1097/01.aids.0000226954.95094.39. AIDS. 2006. PMID: 16691065

7

Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.

ESPRIT Research Group; Fox Z, Antunes F, Davey R, Gazzard B, Klimas N, Labriola A, Losso M, Neaton JD, Phillips AN, Ruxrungtham K, Staszewski S, Weiss L, Lundgren JD. ESPRIT Research Group, et al. Among authors: antunes f. HIV Med. 2007 Mar;8(2):112-23. doi: 10.1111/j.1468-1293.2007.00440.x. HIV Med. 2007. PMID: 17352768 Free article. Clinical Trial.

8

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

Cozzi-Lepri A, Phillips AN, Ruiz L, Clotet B, Loveday C, Kjaer J, Mens H, Clumeck N, Viksna L, Antunes F, Machala L, Lundgren JD; EuroSIDA Study Group. Cozzi-Lepri A, et al. Among authors: antunes f. AIDS. 2007 Mar 30;21(6):721-32. doi: 10.1097/QAD.0b013e3280141fdf. AIDS. 2007. PMID: 17413693

9

Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.

Albuquerque AS, Foxall RB, Cortesão CS, Soares RS, Doroana M, Ribeiro A, Lucas M, Antunes F, Victorino RM, Sousa AE. Albuquerque AS, et al. Among authors: antunes f. Clin Immunol. 2007 Oct;125(1):67-75. doi: 10.1016/j.clim.2007.07.001. Epub 2007 Aug 9. Clin Immunol. 2007. PMID: 17692571

10

The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Borrego P, Marcelino JM, Rocha C, Doroana M, Antunes F, Maltez F, Gomes P, Novo C, Barroso H, Taveira N. Borrego P, et al. Among authors: antunes f. Retrovirology. 2008 Sep 8;5:78. doi: 10.1186/1742-4690-5-78. Retrovirology. 2008. PMID: 18778482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

538 results

Search Page